跳至主要内容
临床试验/NCT03328741
NCT03328741暂停不适用

Evaluation of a Web-based Platform for Osteoarthritis Treatment - a Randomized Clinical Trial

Lund University1 个研究点 分布在 1 个国家目标入组 270 人开始时间: 2018年5月22日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
暂停
入组人数
270
试验地点
1
主要终点
Physical functioning

研究概览

简要总结

This study will compare the effects of a novel web-based program (Joint Academy) to regular face-to-face treatment (the BOA program) for people with osteoarthritis of the knee. Half of the participants will be randomized to the web-based program whilst the other half will receive regular face-to-face care.

详细描述

According to national and international guidelines, osteoarthritis (OA) treatment consists of exercise and information. The face-to-face BOA program is a model to deliver this treatment at primary care facilities in Sweden. Presently less than 20% of people with OA receive adequate treatment. This may be due to lack of healthcare resources or people having trouble to fit their schedule to primary care opening hours. To facilitate a better OA care, alternative methods are therefore required.

A two-armed randomized clinical superiority trial will be performed to compare OA treatment by a web-based program, Joint Academy, with the traditional face-to-face BOA program in 270 adults with clinically verified OA. Using intention-to-treat analysis and per-protocol, evaluations will be performed at baseline, after 6 weeks and after 3, 6 and 12 months. The primary outcome is physical function. Secondary outcomes are joint pain, health-related quality of life, self-reported function, amount of time of physical activity/exercise and overall satisfaction. A health-economic analysis will also be performed. The primary endpoint will be at 12 months. Data will be monitored using web-based questionnaires in Joint Academy, and regular paper questionnaires for the face-to-face treatment.

Should the trial show superiority in favor of Joint Academy, an implementation of the web-based treatment would benefit both patient and society at large, since Joint Academy entails a more flexible treatment in regards to time and location, and is not as costly per-patient as regular face-to-face treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •I: A clinical diagnosis of knee OA according to American College of Rheumatology (ACR) diagnostic criteria as well as national and international guidelines: knee pain and 3 of the following: > 50 years of age, morning stiffness >30 min, crepitus, bony tenderness, bony enlargement, no palpable warmth; II: Reported knee pain ≥4 and ≤8 on the NRS, and ≥6 to ≤16 in number of repetitions of the 30 second chair stand test, at pre-randomization screening.
  • •II: Able to handle a software program via phone, tablet or computer. III: Able to read and write the Swedish language.

排除标准

  • •I: Neurological disease, inflammatory joint disease or cancer. II: Cognitive disorder, e.g. dementia. III: Exercise is contra-indicated for the patient

研究组 & 干预措施

Joint Academy

Experimental

Online osteoarthritis treatment

干预措施: Online Osteoarthritis treatment (Behavioral)

The BOA program

Active Comparator

Face-to-face osteoarthritis treatment

干预措施: Face-to-face osteoarthritis treatment (Behavioral)

结局指标

主要结局

Physical functioning

时间窗: Change from baseline to 6 months (3 months after end of treatment) and at 12 month follow-up

Measured using the 30 second chair stand test, defined in number of repetitions. The result is directly reported after test performance

次要结局

  • NRS pain(Change from baseline to 6 months (3 months after end of treatment) and at 12 month follow-up)
  • Self-reported function(Change from baseline to 6 months (3 months after end of treatment) and at 12 month follow-up)
  • Physical activity(Change from baseline to 6 months (3 months after end of treatment) and at 12 month follow-up)
  • Health-related quality of life(Change from baseline to 6 months (3 months after end of treatment) and at 12 month follow-up)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验